These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8531074

  • 1. Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung.
    Prechel MM, Orawski AT, Maggiora LL, Simmons WH.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1136-42. PubMed ID: 8531074
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation.
    Erşahin C, Simmons WH.
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):96-101. PubMed ID: 9268227
    [Abstract] [Full Text] [Related]

  • 3. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart.
    Dendorfer A, Wolfrum S, Wellhöner P, Korsman K, Dominiak P.
    Br J Pharmacol; 1997 Nov; 122(6):1179-87. PubMed ID: 9401784
    [Abstract] [Full Text] [Related]

  • 4. Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
    Maggiora LL, Orawski AT, Simmons WH.
    J Med Chem; 1999 Jul 01; 42(13):2394-402. PubMed ID: 10395480
    [Abstract] [Full Text] [Related]

  • 5. Characterization of rat pulmonary vascular aminopeptidase P in vivo: role in the inactivation of bradykinin.
    Ryan JW, Berryer P, Chung AY, Sheffy DH.
    J Pharmacol Exp Ther; 1994 Jun 01; 269(3):941-7. PubMed ID: 8014881
    [Abstract] [Full Text] [Related]

  • 6. Cardioprotective effects of the aminopeptidase P inhibitor apstatin: studies on ischemia/reperfusion injury in the isolated rat heart.
    Erşahin C, Euler DE, Simmons WH.
    J Cardiovasc Pharmacol; 1999 Oct 01; 34(4):604-11. PubMed ID: 10511138
    [Abstract] [Full Text] [Related]

  • 7. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
    Wolfrum S, Richardt G, Dominiak P, Katus HA, Dendorfer A.
    Br J Pharmacol; 2001 Sep 01; 134(2):370-4. PubMed ID: 11564655
    [Abstract] [Full Text] [Related]

  • 8. Purification and properties of membrane-bound aminopeptidase P from rat lung.
    Orawski AT, Simmons WH.
    Biochemistry; 1995 Sep 05; 34(35):11227-36. PubMed ID: 7669781
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans.
    Kim KS, Kumar S, Simmons WH, Brown NJ.
    J Pharmacol Exp Ther; 2000 Jan 05; 292(1):295-8. PubMed ID: 10604961
    [Abstract] [Full Text] [Related]

  • 10. Bradykinin metabolism in the liver and lung of the rat.
    Griswold JA, Beall CV, Baker CR, Little DT, Little GH, Behal FJ.
    J Surg Res; 1996 Nov 05; 66(1):12-20. PubMed ID: 8954825
    [Abstract] [Full Text] [Related]

  • 11. Bradykinin metabolism in rat hind limbs.
    Griswold JA, Baker CR, Little DT, Little GH, Behal FJ.
    Shock; 1998 Aug 05; 10(2):146-52. PubMed ID: 9721983
    [Abstract] [Full Text] [Related]

  • 12. Kinin metabolism in the perfused ventilated rat lung. I: Bradykinin metabolism in a system modeling the normal, uninjured lung.
    Baker CR, Little AD, Little GH, Canizaro PC, Behal FJ.
    Circ Shock; 1991 Jan 05; 33(1):37-47. PubMed ID: 2009602
    [Abstract] [Full Text] [Related]

  • 13. Bradykinin metabolism in perfused rat kidney.
    Griswold JA, Baker CR, Little DT, Little GH, Behal FJ.
    Shock; 1999 May 05; 11(5):372-9. PubMed ID: 10353545
    [Abstract] [Full Text] [Related]

  • 14. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO, Bispo-da-Silva LB, Oliveira EB, Resende AC, Salgado MC.
    Hypertension; 2007 Jul 05; 50(1):110-5. PubMed ID: 17470724
    [Abstract] [Full Text] [Related]

  • 15. Degradation of bradykinin, a cardioprotective substance, during a single passage through isolated rat-heart.
    Ahmad M, Zeitlin IJ, Parratt JR, Pitt AR.
    Arch Pharm Res; 2006 Mar 05; 29(3):241-8. PubMed ID: 16596998
    [Abstract] [Full Text] [Related]

  • 16. Membrane-bound aminopeptidase P from bovine lung. Its purification, properties, and degradation of bradykinin.
    Simmons WH, Orawski AT.
    J Biol Chem; 1992 Mar 05; 267(7):4897-903. PubMed ID: 1537867
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of the vascular response to kinins by inhibition of myocardial kininases.
    Dendorfer A, Wolfrum S, Schäfer U, Stewart JM, Inamura N, Dominiak P.
    Hypertension; 2000 Jan 05; 35(1 Pt 1):32-7. PubMed ID: 10642271
    [Abstract] [Full Text] [Related]

  • 18. Effects of the aminopeptidase P inhibitor apstatin on bradykinin-induced inositol 1,4,5-triphosphate in neonatal rat cardiomyocytes.
    Kudoh A, Kudoh E, Katagai H, Takazawa T.
    J Cardiovasc Pharmacol; 2001 May 05; 37(5):495-501. PubMed ID: 11336100
    [Abstract] [Full Text] [Related]

  • 19. Bradykinin metabolism in the isolated perfused rabbit heart.
    Taylor-McCabe KJ, Erşahin C, Simmons WH.
    J Hypertens; 2001 Jul 05; 19(7):1295-9. PubMed ID: 11446720
    [Abstract] [Full Text] [Related]

  • 20. Conversion of T-kinin to bradykinin by the rat kidney.
    Vieira MA, Moreira MF, Maack T, Guimarães JA.
    Biochem Pharmacol; 1994 Apr 29; 47(9):1693-9. PubMed ID: 8185685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.